Faculty of Sciences, BioISI-Biosystems and Integrative Sciences Institute, University of Lisboa, Lisboa, Portugal.
The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.
J R Soc Interface. 2019 Aug 30;16(157):20190187. doi: 10.1098/rsif.2019.0187. Epub 2019 Aug 28.
The lung epithelium is lined with a layer of airway surface liquid (ASL) that is crucial for healthy lung function. ASL thickness is controlled by two ion channels: epithelium sodium channel (ENaC) and cystic fibrosis (CF) transmembrane conductance regulator (CFTR). Here, we present a minimal mathematical model of ENaC, CFTR and ASL regulation that sheds light on the control of ENaC by the short palate lung and nasal epithelial clone 1 (SPLUNC1) protein and by phosphatidylinositol 4,5-biphosphate (PI(4,5)P). The model, despite its simplicity, yields a good fit to experimental observations and is an effective tool for exploring the interplay between ENaC, CFTR and ASL. Steady-state data and dynamic information constrain the model's parameters without ambiguities. Testing the hypothesis that PI(4,5)P protects ENaC from ubiquitination suggests that this protection does not improve the model results and that the control of the ENaC opening probability by PI(4,5)P is sufficient to explain all available data. The model analysis further demonstrates that ASL at the steady state is sensitive to small changes in PI(4,5)P abundance, particularly in CF conditions, which suggests that manipulation of phosphoinositide metabolism may promote therapeutic benefits for CF patients.
肺上皮细胞由一层气道表面液体(ASL)覆盖,这对于肺部的健康功能至关重要。ASL 的厚度由两种离子通道控制:上皮钠离子通道(ENaC)和囊性纤维化跨膜电导调节因子(CFTR)。在这里,我们提出了一个简化的 ENaC、CFTR 和 ASL 调节的数学模型,该模型阐明了短腭肺和鼻上皮克隆 1(SPLUNC1)蛋白以及磷脂酰肌醇 4,5-二磷酸(PI(4,5)P)对 ENaC 的控制作用。该模型虽然简单,但与实验观察结果拟合得很好,是探索 ENaC、CFTR 和 ASL 之间相互作用的有效工具。稳态数据和动态信息限制了模型参数,没有任何歧义。通过测试 PI(4,5)P 保护 ENaC 免受泛素化的假设,表明这种保护并不能改善模型结果,PI(4,5)P 对 ENaC 开放概率的控制足以解释所有现有数据。模型分析还进一步表明,在稳态下,ASL 对 PI(4,5)P 丰度的微小变化敏感,尤其是在 CF 条件下,这表明对磷酸肌醇代谢的操纵可能会为 CF 患者带来治疗益处。